Michael S. Conte


Co-director, Heart & Vascular Center
Vascular surgeon

About me

Dr. Michael S. Conte is a vascular surgeon who specializes in diseases of the aorta and its major branches, aneurysms, carotid artery disease and peripheral artery disease (PAD). He also treats diabetic vascular disease and performs complex revascularization (restoration of blood flow) to preserve limb function and prevent amputation.

Conte is co-director of the UCSF Heart & Vascular Center and chief of the Division of Vascular & Endovascular Surgery.

Conte led the largest multicenter clinical trial to date of leg bypass surgery in patients with severe PAD. He is studying angioplasty and bypass surgery failure, and how to identify patients at risk.

Conte earned his medical degree at Albert Einstein College of Medicine. He completed a surgical residency at Weill Cornell Medicine, followed by vascular surgery training in the John Homans fellowship at Brigham and Women's Hospital and Harvard Medical School.

Conte is a member of the Society for Vascular Surgery and Society of University Surgeons. In 2006, he received a distinguished achievement award from the New York Weill Cornell Medical Center Alumni Council. He serves on the editorial boards for several medical journals, including Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery and Vascular.

  • Education

    Albert Einstein College of Medicine, 1986

  • Residencies

    Cornell Medical Center, General Surgery, 1993

  • Fellowships

    Brigham and Women's Hospital, Vascular Surgery, 1991

    Harvard Medical School, Vascular Surgery, 1994

    Brigham and Women's Hospital, Vascular Surgery, 1994

  • Board Certifications

    Vascular Surgery, American Board of Surgery

  • Academic Title


  • Languages


Center for Aortic Disease

400 Parnassus Ave., Suite 501
San Francisco, CA 94143

Center for Limb Preservation

400 Parnassus Ave., Room A-501
San Francisco, CA 94143

Vascular and Endovascular Surgery Clinic

400 Parnassus Ave., Suite 501
San Francisco, CA 94143

Vascular Laboratory at Parnassus

400 Parnassus Ave., Fifth Floor, Suite 501
San Francisco, CA 94143

Berkeley Outpatient Center

3100 San Pablo Ave.
Berkeley, CA 94702

My reviews


Overall Experience
179 Reviews
Dr. Conte is an excellent care provider. He takes the time required to provide a thorough explanation of my health condition and any addresses any concerns I might have.
Explained things in a way that was easy to understand
177 Reviews
Did the doctor pay attention to your concerns
177 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
162 Reviews
Knew the important information about your medical history
176 Reviews
The provider showed respect for what you had to say
176 Reviews
The provider spent enough time with me
175 Reviews
Decorative Caduceus

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

The primary effectiveness endpoint assesses primary patency using duplex ultrasound at 6 months post-procedure.


Decorative Caduceus

The PROMISE II Trial, Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Ch...

freedom from major amputation and death at 6 months, compared to a historical performance goal.


Decorative Caduceus

C-myc Biomarker Study for Diabetic Foot Ulcers


Decorative Caduceus

TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence


Decorative Caduceus

Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee Oxygen Platform in Correlation ...

Correlation of measurements between subcutaneous tissue oxygen concentration expressed by the Lumee Oxygen Index (LOI; unitless; measured by the Wireless Lumee Oxygen Platform) and transcutaneous partial pressure of oxygen (TcPO2;...


Decorative Caduceus

THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peri...

The smallest dose administered in Phase 1a participants which results in an increase in Resolution Index at least 3 times that of baseline, or the subsequent larger dose resulting in a Resolution Index greater than 2 times that of...